gossypii and B
Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs. Science (New York, N.Y.) , vol
For some individuals, this dual action provides a stronger signal to the brain and gut, potentially leading to better appetite suppression for those who were non-responders to semaglutide
Ok yall..maybe Im crazy but I thought there would be a bigger difference by now
Technical/expert advice for this project was provided by the Michigan Center for Diabetes Translational Research (Grant P30DK092926 from the National Institute of Diabetes and Digestive and Kidney Diseases) (Shihchen Kuo)
Research has identified these alarming vision-related risks associated with GLP-1 medications: Sudden irreversible vision loss: NAION strikes without warning, often discovered upon waking, causing blurry or dim vision that progresses to immediate and permanent partial or complete blindness in the affected eye with no possibility of restoration Elevated risk across multiple studies: Beyond the Harvard findings showing 4-7 fold increased risk, a University of Southern Denmark study examining over 424,000 patients found weekly semaglutide users faced 2.19 times higher NAION risk European regulatory recognition: In June 2025, the European Medicines Agency officially recognized NAION as a possible side effect of semaglutide medications, marking formal acknowledgment by international regulators Complete absence of treatment options: Medical science currently offers no cure, no effective treatment, and no way to reverse NAION-related vision damage, leaving patients with permanent disability The permanent and irreversible nature of NAION-related optic nerve damage distinguishes these injuries from other complications that may resolve after discontinuing medication
